ÃÑ 196ÆäÀÌÁö

3ÆäÀÌÁö º»¹®½ÃÀÛ

1. À¯ÀüÀÚ°¡À§ ±â¼úÀÇ ¼öÀÇÇÐÀû ÀÀ¿ë¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
1
±¸¿ÁÀç ¹Ú»ç / ¢ßÅøÁ¨
2. Àû¿Ü¼± Èí¼öºÐ±¤À» ÀÌ¿ëÇÑ À¯±â¹° ŽÁö ¹× »ý»ç¿©ºÎ ÆÇ´Ü ±â¼ú ¼Ò°³¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
13
½Å»ó¸ð ±³¼ö / ±¹¸³Çѹç´ëÇб³
3. ¸ð±â¸Å°³ ¾ËÆĹÙÀÌ·¯½ºÀÇ Æ¯¼ººÐ¼®°ú À̸¦ ÀÌ¿ëÇÑ ´Ù¾çÇÑ ÀÀ¿ë¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
17
±è´Þ¿µ ¹Ú»ç / City University of Hong Kong College
4. ½Ä¹°À» ÀÌ¿ëÇÑ Áúº´¿¹¹æ ¹× Ä¡·áÁ¦ °³¹ß¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
33
°í±â¼º ±³¼ö / Áß¾Ó´ëÇб³
5. ¹ÙÀÌ·¯½º ´Ü¹éÁú Ç׿øÀ» ÀÌ¿ëÇÑ Áø´Ü ¹× ¹é½Å±â¼ú°³¹ß¿¬±¸¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
53
Á¤´ë±Õ ¹Ú»ç / Çѱ¹»ý¸í°øÇבּ¸¿ø
6. ±¹°¡º´¿øüÀÚ¿øÀºÇà ¿î¿µ °íµµÈ­¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
67
Ȳ±ÔÀá ÆÀÀå / Áúº´°ü¸®º»ºÎ º´¿øüÀÚ¿ø°ü¸® TF
7. New paradigm of vaccine development based on novel adjuvant¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 77
±èµ¿È£ ¹Ú»ç /NA Vaccine Institute
8. ¹Ý·Á°ßÀÇ ¾Ï¿¡ ´ëÇÑ Ç׾ϹÙÀÌ·¯½ºÀÇ Ä¡·áÀû Àû¿ë¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
85
¹ÚÁؼ® ¹Ú»ç / ´ë±¸°æºÏ÷´ÜÀÇ·á»ê¾÷ÁøÈïÀç´Ü

3ÆäÀÌÁö º»¹®³¡



ÇöÀç Æ÷Ä¿½ºÀÇ ¾Æ·¡³»¿ëµéÀº µ¿ÀÏÇÑ ÄÁÅÙÃ÷¸¦ °¡Áö°í ÆäÀÌÁö³Ñ±è È¿°ú¹× ½Ã°¢Àû È¿°ú¸¦ Á¦°øÇÏ´Â ÆäÀÌÁöÀ̹ǷΠ½ºÅ©¸°¸®´õ »ç¿ëÀÚ´Â ¿©±â±îÁö¸¸ ³¶µ¶ÇϽðí À§ÀÇ ÆäÀÌÁöÀ̵¿ ¸µÅ©¸¦ »ç¿ëÇÏ¿© ´ÙÀ½ÆäÀÌÁö·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
»ó´Ü¸Þ´º ¹Ù·Î°¡±â ´ÜÃàÅ°¾È³» : ÀÌÀüÆäÀÌÁö´Â ÁÂÃø¹æÇâÅ°, ´ÙÀ½ÆäÀÌÁö´Â ¿ìÃø¹æÇâÅ°, ùÆäÀÌÁö´Â »ó´Ü¹æÇâÅ°, ¸¶Áö¸·ÆäÀÌÁö´Â ÇϴܹæÇâÅ°, ÁÂÃøÈ®´ëÃà¼Ò´Â insertÅ°, ¿ìÃøÈ®´ëÃà¼Ò´Â deleteÅ°